Oppenheimer Maintains an 'Outperform' on Curis (CRIS); Good Q2, Now Milestones Become Focus
Tweet Send to a Friend
Oppenheimer maintains an 'Outperform' on Curis (NASDAQ: CRIS) price target of $5.50.
Analyst, Boris Peaker, said, "Curis reported 2Q12 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Boris Peaker, said, "Curis reported 2Q12 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
